Please assess the completion status of the following clinical trial:

Trial Title: LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Multiethnic subjects~* 18 to 50 YO~* Phototype III-VI~* All skin types~* 50% with sensitive skin (declarative)~* Symmetrical mild to moderate facial post-acne PIHP lesions with IGA scale~* Mild active acne (less than 10 retention and 5 inflammatory lesions)~* Agreeing not to change their lifestyle during the study period.~* Capable of reading the documents presented to them, of adhering to the study regulations and accepting the limitations.~* Available to follow the study~* Agreeing to participate and having signed the informed consent~Exclusion Criteria:~* Moderate to severe active acne~* Patients under topical or systemic retinoids~* Patients under systemic immunosuppressants~* Patients under active treatment of PIHP (including topicals or procedures) within the last 3 months~* Patients treated with facial procedures within the last 3 months~* Pregnancy~* Patient with a recent change in contraception (since less than 6 months)~* Known allergy to any component of tested product~* Not presenting with the conditions needed to comply with the protocol.~* Unable to give their informed consent~* Not available to follow the study in its entirety

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Control Group (Type: ACTIVE_COMPARATOR): Participant will receive sunscreen in the morning and at the beginning of the afternoon for 3 months.
- Liftactiv B3 (Type: EXPERIMENTAL): Participants will undergo a wash out phase of two weeks where they regularly apply a moisturizer (Hydreane Legere) in the morning and a sunscreen in the morning and at the beginning of the afternoon. On the 3rd week, participants will apply Liftactiv B3 serum daily in the morning before sunscreen and in the evening (two applications daily) on half face for 3 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).